The global threat

Search for a cure

The need for a COVID-19 breakthrough

Viral infections are a major and continuing global healthcare threat. Respiratory viral infections have reached epidemic and pandemic magnitude – and there is clear need for novel enhanced antiviral agents.

Deadly viral diseases such as influenza, HIV, AIDS, Zika virus, dengue and SARS-CoV-2 have emerged and their spread globally has become faster and more dangerous.

In the fight against these viruses, there is a clearly understood need for effective antiviral therapeutics in addition to vaccines.

Looking to invest?

Click below to find out more about investment opportunities.